As of November 6, 2026, TELA Bio, Inc. is a publicly traded company (Nasdaq: TELA). The largest holder reporting an active stake on Schedule 13D is EW Healthcare Partners Fund 2, L.P., at 17.23%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D, June 9, 2026).
Is this your company?
About to sign with, pay or invest in TELA Bio, Inc.? See the free Snapshot first.
Free to see. No signup.
Is TELA Bio, Inc. a real, registered company?
- TELA Bio, Inc. files with the SEC under CIK 1561921 (its SEC filings).
- Its shares are listed under the ticker TELA on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Malvern, Pennsylvania, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under TELA BIO, INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-08-31, about 201 jobs).
- Leadership changes: the latest reported is Antony Koblish, Director (Form 8-K filed 2026-08-04). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Nantahala Capital (filed 2026-08-14).
Who are TELA Bio, Inc.'s owners and officers?
TELA Bio, Inc.: incorporated in Delaware; business address in Malvern, Pennsylvania; industry Surgical & Medical Instruments & Apparatus (Form 8-K, 2026-08-31).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Silverarc Capital Management, LLC | 4.8% |
| Schedule 13G/A, 2026-08-14 | Nantahala Capital Management, LLC | 12.94% |
| Schedule 13G, 2026-08-11 | Silverarc Capital Management, LLC | 4.8% |
| Schedule 13D, 2026-06-09 | Ew Healthcare Partners Fund 2, L.P. | 17.23% |
| Schedule 13G/A, 2026-05-15 | Lytton, Laurence W. | 5.5% |
| Schedule 13G/A, 2025-11-17 | Ew Healthcare Partners Fund 2 Gp, L.P. | 17.32% |
| Schedule 13G/A, 2025-11-14 | Lytton, Laurence W. | 7.2% |
| Schedule 13G/A, 2025-10-15 | Grow Funds, LLC. | — |
| Schedule 13G/A, 2025-08-14 | Lytton, Laurence W. | 8.5% |
Questions about who owns TELA Bio, Inc.
Who owns TELA Bio, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of TELA Bio, Inc.: Ew Healthcare Partners Fund 2 Gp, L.P. (17.32%, Schedule 13G/A, filed 2025-11-17), Ew Healthcare Partners Fund 2, L.P. (17.23%, Schedule 13D, filed 2026-06-09), Nantahala Capital Management, LLC (12.94%, Schedule 13G/A, filed 2026-08-14) and Lytton, Laurence W. (5.5%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of TELA Bio, Inc.?
By the share each holder's latest filing reports, the largest holders of TELA Bio, Inc. on this page are Ew Healthcare Partners Fund 2 Gp, L.P. (17.32%), Ew Healthcare Partners Fund 2, L.P. (17.23%) and Nantahala Capital Management, LLC (12.94%).
When did Ew Healthcare Partners Fund 2 Gp, L.P. buy into TELA Bio, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Ew Healthcare Partners Fund 2 Gp, L.P. on this page is the Schedule 13G/A, filed 2025-11-17, reporting 17.32%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on TELA Bio, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TELA Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TELA Bio, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-04 | Antony Koblish | Director | departed | |
| Form 8-K, 2026-04-30 | Guido Neels | Director | appointed |
Which insiders own TELA Bio, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- EW Healthcare Partners Fund 2 GP, L.P., a 10% owner: 7,714,709 shares (17.2% of shares outstanding), on a joint filing (Form 4, 2025-11-17).
- EW Healthcare Partners Fund 2-A, L.P., a 10% owner: 7,714,709 shares (17.2% of shares outstanding), on a joint filing (Form 4, 2025-11-17).
- EW Healthcare Partners Fund 2, L.P., a 10% owner: 7,714,709 shares (17.2% of shares outstanding), on a joint filing (Form 4, 2025-11-17).
- EW Healthcare Partners Fund 2-UGP, LLC, a 10% owner: 7,714,709 shares (17.2% of shares outstanding), on a joint filing (Form 4, 2025-11-17).
- , the chief executive and a director: 586,210 shares (1.3% of shares outstanding) (Form 4, 2026-02-24).
Shares outstanding: 44,894,757 as of 2026-08-05, from the company's latest SEC cover page.
How much has TELA Bio, Inc. raised?
No fundraising or offering filing from TELA Bio, Inc. is on file with us.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-08-31).
Keep reading
More on TELA Bio, Inc. and the records around it.
TELA Bio, Inc. elsewhere on the record
- Leadership changes Aug 2026
- Layoff notices Aug 2026
- 5%+ stake filings Aug 2026
Companies that share a holder
- GROW FUNDS, LLC. also filed stake reports on 2 other companies: BranchOut Food Inc. (Oct 2026), BUDA JUICE, INC. (Mar 2026)
- SilverArc Capital Management, LLC also filed stake reports on 8 other companies: Cellectar Biosciences Inc (Aug 2026), ELUTIA INC. (Aug 2026), Fractyl Health Inc (May 2026)
- Lytton, Laurence W. also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
Related pages
LayoffsLeadership changes5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/tela-bio